The CAPS Screen: 5 All-Star Dividend Stocks

Recs

1

I've noted before that dividend investing is a tried-and-true strategy for building long-term wealth. In fact, a study by Ned Davis Research found that dividend-paying stocks have outperformed their stingier counterparts 10% vs. 4% annually from 1972 to 2006.

In other words, you can generate sizable investment returns even during times of market turmoil if you can identify dividend stocks that will set you for life.

In order to find dividend studs like Johnson & Johnson (NYSE: JNJ) and Pfizer (NYSE: PFE), which have grown their respective dividends 15% and 17%, respectively, over the past five years, I used the Fool's new CAPS screening tool.

Below are five companies which have been rated to outperform the market by more than 50 All-Stars, CAPS members whose track records rank them in the top 20th percentile of our 115,000-member (and growing!) investing community.

These stocks also have:

  • Market caps greater than $2 billion.
  • Dividend yields greater than 2%.
  • Four- or five-star ratings from our CAPS community.

In the first 20 months after we began tracking the collective intelligence of our CAPS investment community in November 2006, four-star companies outperformed the market on average by 7% annualized. Five-star stocks did even better.

Company

Sector

Dividend Yield

All-Stars Rating Outperform

Intel Corp (Nasdaq: INTC)

Technology

3.5%

1238 / 1360

ExxonMobil (NYSE: XOM)

Basic Materials

2.2%

1238 / 1360

General Electric (NYSE: GE)

Conglomerates

5.9%

1192 / 1307

Honda Motors (NYSE: HMC)

Consumer Goods

3.4%

340 / 353

J.M. Smucker (NYSE: SJM)

Consumer Goods

2.8%

57 / 59

Data from Motley Fool CAPS, Yahoo! Finance as of Oct. 16, 2008.

Remember, this screen is only a starting point in the research process. When selecting dividend payers, Fools know it's important to make sure a company has sufficient free cash flow to sustain and grow its dividends for years to come.

Follow along with the Global Gains team as they travel to key business centers in China to uncover the very best investing opportunities! Sign up here to receive their FREE dispatches from the road.

Ilan Moscovitz doesn't own shares of any companies mentioned in this article. He thinks the CAPS screen is the new four-square. Pfizer and Johnson & Johnson are Income Investor recommendations. Pfizer and Intel are Inside Value picks. The Fool owns shares of Pfizer. Try any of our Foolish newsletters today, free for 30 days. The Fool's disclosure policy calls spikes.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 755565, ~/articles/ArticleHandler.aspx, 7/6/2009 3:28:54 AM

Keep Reading:

“The CAPS Screen: 5 All-Star Dividend Stocks”

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Get involved! »

Most Recent

Jul 2 at 4:22 PM

Market Summary

DJIA 8,280.74 -223.32 -2.63%
S&P 500 896.42 -26.91 -2.91%
NASD 1,796.52 +0.00 +0.00%
Sponsored by:

Related Tickers

Johnson & Johnson

CAPS Rating 5/5 Stars

$55.98

-1.09 (-1.91%)

Outperform11704

Underperform409

Rate This Stock